HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Achim Hoerauf Selected Research

N-acetyltyramine

8/2021Urine metabolites for the identification of Onchocerca volvulus infections in patients from Cameroon.
1/2017Validation of onchocerciasis biomarker N-acetyltyramine-O-glucuronide (NATOG).
12/2015Litomosoides sigmodontis: a jird urine metabolome study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Achim Hoerauf Research Topics

Disease

81Infections
06/2022 - 04/2002
54Onchocerciasis
01/2022 - 01/2002
35Filarial Elephantiasis (Lymphatic Filariasis)
01/2022 - 02/2003
19Filariasis
12/2021 - 05/2002
10Intestinal Volvulus (Volvulus)
08/2021 - 08/2009
8Loiasis
01/2022 - 01/2009
8Inflammation (Inflammations)
01/2020 - 02/2008
8Malaria
01/2019 - 01/2004
7Coinfection
01/2022 - 09/2008
6Cerebral Malaria
01/2021 - 08/2010
6Ocular Onchocerciasis (River Blindness)
01/2020 - 11/2002
6Infertility (Sterility)
01/2018 - 04/2003
5Neglected Diseases
01/2022 - 03/2013
4Lymphedema (Milroy Disease)
01/2019 - 09/2006
3Reinfection
02/2020 - 03/2004
3Insulin Resistance
01/2019 - 01/2016
3Peritonitis
01/2016 - 01/2014
2Tuberculosis (Tuberculoses)
06/2022 - 07/2012
2COVID-19
01/2022 - 01/2021
2Elephantiasis
07/2021 - 03/2020
2Body Weight (Weight, Body)
11/2020 - 01/2016
2Mansonelliasis
01/2019 - 01/2016
2Foreign Bodies (Foreign Body)
06/2018 - 12/2017
2Latent Infection
01/2018 - 11/2011
2Necrosis
01/2018 - 11/2008
2Ascites
11/2015 - 01/2014
2Fibrosis (Cirrhosis)
11/2015 - 01/2014
2Liver Cirrhosis (Hepatic Cirrhosis)
11/2015 - 01/2014
2Sepsis (Septicemia)
01/2015 - 11/2013
2Asthma (Bronchial Asthma)
02/2008 - 01/2002
2Pulmonary Eosinophilia (Eosinophilic Pneumonia)
02/2008 - 11/2003
2Lassa Fever (Fever, Lassa)
03/2004 - 01/2002
1Asymptomatic Infections
01/2022
1Schistosomiasis mansoni
12/2021
1Sexually Transmitted Diseases (Sexually Transmitted Disease)
01/2021

Drug/Important Bio-Agent (IBA)

32Doxycycline (Periostat)FDA LinkGeneric
06/2022 - 04/2003
29Ivermectin (Mectizan)FDA Link
01/2022 - 04/2003
27Pharmaceutical PreparationsIBA
01/2022 - 10/2003
20Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 04/2002
16Interleukin-10 (Interleukin 10)IBA
01/2019 - 11/2002
14CytokinesIBA
02/2020 - 01/2002
13AntigensIBA
06/2022 - 11/2002
13Immunoglobulin G (IgG)IBA
01/2022 - 07/2004
11Albendazole (Albenza)FDA Link
01/2022 - 04/2006
11Proteins (Proteins, Gene)FDA Link
11/2017 - 02/2005
9Interleukin-5 (Interleukin 5)IBA
05/2019 - 11/2002
8AntibodiesIBA
01/2022 - 03/2004
7Diethylcarbamazine (Hetrazan)FDA Link
01/2022 - 05/2008
6corallopyronin AIBA
01/2022 - 07/2012
6Biomarkers (Surrogate Marker)IBA
08/2021 - 03/2013
5VaccinesIBA
01/2022 - 01/2002
5Interleukin-13IBA
03/2015 - 01/2002
5Interleukin-4 (Interleukin 4)IBA
03/2006 - 11/2002
4ChemokinesIBA
02/2020 - 01/2015
4Tetracycline (Achromycin)FDA LinkGeneric
01/2019 - 05/2003
4Transforming Growth Factor beta (TGF-beta)IBA
07/2010 - 02/2008
3GlucuronidesIBA
08/2021 - 12/2015
3N-acetyltyramineIBA
08/2021 - 12/2015
3DNA (Deoxyribonucleic Acid)IBA
01/2021 - 03/2014
3Interleukin-17 (Interleukin 17)IBA
01/2019 - 03/2015
3Immunoglobulin E (IgE)IBA
07/2017 - 01/2002
3LigandsIBA
01/2017 - 11/2008
3Rifampin (Rifampicin)FDA LinkGeneric
07/2012 - 05/2003
3Interleukin-12 (IL 12)IBA
09/2011 - 07/2004
2Helminth AntigensIBA
01/2022 - 03/2016
2Monoclonal AntibodiesIBA
01/2022 - 01/2015
2Immunoglobulins (Immunoglobulin)IBA
12/2021 - 02/2020
2SolutionsIBA
01/2021 - 01/2019
2Leukocyte L1 Antigen Complex (Calgranulin)IBA
01/2020 - 11/2015
2QuinazolinesIBA
01/2020 - 01/2019
2Minocycline (Cyclops)FDA LinkGeneric
01/2019 - 01/2017
2Interleukin-4 Receptors (Interleukin 4 Receptor)IBA
01/2019 - 01/2004
2Interleukin-6 (Interleukin 6)IBA
10/2018 - 03/2015
2RNA (Ribonucleic Acid)IBA
01/2018 - 01/2017
2OligonucleotidesIBA
01/2017 - 09/2011
2muramyl- NAc- (pentapeptide)pyrophosphoryl- undecaprenolIBA
12/2016 - 09/2009
2InterferonsIBA
05/2015 - 01/2011
2Apolipoproteins C (ApoC)IBA
01/2014 - 08/2009
2Interferon-gamma (Interferon, gamma)IBA
09/2011 - 12/2003
2Vascular Endothelial Growth Factor CIBA
12/2009 - 09/2006
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2009 - 10/2007
2deoxyhypusine synthaseIBA
05/2008 - 08/2006
2EnzymesIBA
05/2008 - 10/2006
2Peptide Initiation Factors (Initiation Factor)IBA
09/2007 - 08/2006
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2004 - 01/2002
1Polysaccharides (Glycans)IBA
01/2022
1Peptides (Polypeptides)IBA
01/2022
1emodepsideIBA
12/2021
1tetraphenylporphine sulfonate (TPPS)IBA
11/2021
1cinnamoylglycineIBA
08/2021
1ClayIBA
07/2021
1Biological ProductsIBA
01/2021
1Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA
01/2021

Therapy/Procedure

14Mass Drug Administration
01/2022 - 12/2008
12Therapeutics
11/2020 - 04/2002
7Aftercare (After-Treatment)
10/2020 - 02/2006
6Drug Therapy (Chemotherapy)
03/2020 - 11/2003
5Immunomodulation
01/2021 - 08/2010
2Arthroplasty
12/2017 - 02/2016
1Contraception (Birth Control)
01/2021